Oral semaglutide for weight loss and liver fibrosis in overweight and obesity: A randomized controlled trial. Katrevula A, Kalapala R, Agrawal S, Jagtap N, et al. Indian J Gastroenterol 2026;45:872-883.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Katrevula A, Kalapala R, Agrawal S, Jagtap N, et al. Oral semaglutide for weight loss and liver fibrosis in overweight and obesity: A randomized controlled trial. Indian J Gastroenterol 2026;45:872-883.
PMID: 41066034